BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 23708054)

  • 21. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of colorectal tumours in daily clinical practice: comparison of colonoscopy and sigmoidoscopy].
    Terhaar sive Droste JS; van Wanrooij RL; Morsink LM; van der Hulst RW; Craanen ME; Bartelsman JW; Meijer GA; Mulder CJ
    Ned Tijdschr Geneeskd; 2009; 153():A731. PubMed ID: 20003556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.
    Brenner H; Hoffmeister M; Arndt V; Stegmaier C; Altenhofen L; Haug U
    J Natl Cancer Inst; 2010 Jan; 102(2):89-95. PubMed ID: 20042716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies.
    Niedermaier T; Weigl K; Hoffmeister M; Brenner H
    Eur J Epidemiol; 2018 May; 33(5):473-484. PubMed ID: 29752577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
    Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
    Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program.
    Shapero TF; Hoover J; Paszat LF; Burgis E; Hsieh E; Rothwell DM; Rabeneck L
    Gastrointest Endosc; 2007 Apr; 65(4):640-5. PubMed ID: 17173913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
    Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
    J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies.
    Jover R; Zapater P; Polanía E; Bujanda L; Lanas A; Hermo JA; Cubiella J; Ono A; González-Méndez Y; Peris A; Pellisé M; Seoane A; Herreros-de-Tejada A; Ponce M; Marín-Gabriel JC; Chaparro M; Cacho G; Fernández-Díez S; Arenas J; Sopeña F; de-Castro L; Vega-Villaamil P; Rodríguez-Soler M; Carballo F; Salas D; Morillas JD; Andreu M; Quintero E; Castells A;
    Gastrointest Endosc; 2013 Mar; 77(3):381-389.e1. PubMed ID: 23218945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials.
    Holme Ø; Schoen RE; Senore C; Segnan N; Hoff G; Løberg M; Bretthauer M; Adami HO; Kalager M
    BMJ; 2017 Jan; 356():i6673. PubMed ID: 28087510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.
    Niedermaier T; Weigl K; Hoffmeister M; Brenner H
    Eur J Epidemiol; 2017 Jun; 32(6):481-493. PubMed ID: 28667446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of subjects at risk of proximal advanced neoplasia for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Wong SH; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
    Eur J Cancer; 2015 Jan; 51(1):37-44. PubMed ID: 25459390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.